奥沙利铂联合氟尿嘧啶、亚叶酸钙治疗晚期大肠癌疗效观察
出处
《中国基层医药》
CAS
2004年第5期622-623,共2页
Chinese Journal of Primary Medicine and Pharmacy
二级参考文献41
-
1Li X M，Arch Toxicol，1998年，72卷，9期，574页
-
2Itamoto T, Asahara T, Kohashi T, et al. Hepatic arterial infusion oflow-dosecisplatin, 5 - fluorouracil for hepatocellular carcinomawith tumor thrombi in the portalvein. Jpn J Cancer Chemother,1999, 26(12): 1832 - 1835
-
3Chu L, Sutton LM, Peterson Bl, et al. Continuous infusion 5 - FUas first - linetherapy for metastatic brest cancer. J InfusChemother, 1996, 6(4) :211 - 216
-
4Azim HA. Treatment of metastic brest cancer by naveblinmitoantrone and continuousinfusion 5 - Fu: results of a pilot study.J Infus Chemother, 1996, 6(2): 102 - 106
-
5Saji S, Aiba K, Araki K, et al. Current status of low - dose CDDP,5 - Fu therapyfor solid malignant tumors- nationwide questionnairesurvey. Jpn J Cancer Chemother, 1997,26(13): 1892 - 1900
-
6Sasaki K, Hirata K, Denno R, et al. Combination chemotherapy ofcontinuous infusion5 - fluorouracil and daily low - dose cisplain inadvanced gastrointestinal and lungadenocarcinoma. Jpn J CancerChemother, 1997, 24(8) :959 - 964
-
7Tsuji A, Morita S, Horimi T, et al. Preliminary clinical evalution oflow- doseCDDP and continuous 5 - FU therapy for advancedgallbladder cancer. Jpn J Cancer Chemother,2000, 27 (2) :233 - 237
-
8Shimizu Y, Husumi K. Chemotherapy with consecutive low - doseCDDP combined with 5- FU for gynecologic malignancies. Jpn JCancer Chemother, 19999, 26 ( 11 ): 1569 - 1574
-
9Sakaihara M, Sakai K, Hara Y, et al. Successful treatment of apatient withrecurrent ovarian clear cell adenocarcinoma undercombination chemotherapy of 5 - FU andlow - dose CDDP. Jpn JCancer Chemother, 2000, 27( 1 ): 127 - 130
-
10Fujinami K, Kubota Y. Combination chemotherapy with 5 - FU andlow - dose CDDP forurogenital tumors. Jpn J Cancer Chemother,1999, 26( 11 ): 1559 - 1563
共引文献347
-
1朱秋秋,梁廷明,郭霞庆.奥沙利铂联合治疗大肠癌复发转移36例临床观察[J].南通大学学报（医学版）,2008,28(1):55-56.
-
2黄韵坚,黄诚,庄武,许凌,林金兰.吉西他滨联合奥沙利铂或顺铂治疗晚期非小细胞肺癌的随机对照研究[J].中华肿瘤防治杂志,2008,15(12):924-926. 被引量：8
-
3李海金,董良,李英,符淑媛.艾迪注射液联合吉西他滨加奥沙利铂(GO)治疗晚期非小细胞肺癌的临床研究[J].中国肺癌杂志,2008,11(4):570-573. 被引量：2
-
4陈红宇,朱婷,鲍健.奥沙利铂与氟尿嘧啶 亚叶酸钙联合治疗晚期大肠癌的临床观察[J].安徽医学,2009,30(3):311-312. 被引量：2
-
5李春艳,李庆云,徐静.FOLFOX4方案治疗晚期胃癌46例临床观察[J].中国实用医药,2007,2(31):100-101.
-
6曹关义,刘霞,李维前,刘斌.TRAIL联合5-Fu对结肠癌细胞的增殖抑制作用及机制探讨[J].山东医药,2013,53(30):16-20. 被引量：2
-
7钱洪,金涌.奥沙利铂联合氟尿嘧啶及亚叶酸钙治疗晚期胃癌24例[J].肿瘤研究与临床,2008,20(2):127-128. 被引量：1
-
8付方现,刘俊叶,李永锋,韩文青,冯献明.FOLFOX4方案治疗晚期胃癌65例[J].肿瘤研究与临床,2008,20(7):486-488. 被引量：7
-
9王春森,王晓冬,祝彪,张晋林.奥沙利铂联合阿糖胞苷及地塞米松治疗难治性或复发性非霍奇金淋巴瘤[J].白血病．淋巴瘤,2008,17(1). 被引量：3
-
10李绮云.艾恒联合亚叶酸钙及5-氟脲嘧啶持续输注治疗晚期大肠癌的近期疗效分析[J].河南肿瘤学杂志,2004,17(4):254-255.
-
1林浩.常见癌症及其表现[J].家庭医学（上半月）,2007(8):8-8.
-
2靳黎明,杨以良.老年常见癌症的早期信号[J].解放军健康,2002(4):32-32.
-
3Giles Bond-Smith Need Banga Toby M Hammond Charles J lmber.胰腺癌[J].英国医学杂志中文版,2012,15(4):222-228.
-
4秦彦.香港检测常见癌症的方法[J].抗癌,2002(4):38-39.
-
5李静.再谈甲状腺乳头状癌诊治中的“过度”[J].中华内科杂志,2017,56(1):7-10. 被引量：4
-
6臧恒佳（译）.富含大豆的食品减少前列腺癌发生的风险[J].抗癌,2012,24(1):38-39.
-
7吴文川,靳大勇.大肠癌的基因治疗研究[J].中国临床医学,2002,9(6):753-754.
-
8廖洪(译),杨勇(校).前列腺癌治疗后尿失禁——尽早向专家中心转诊可减少长期患病率[J].英国医学杂志中文版,2012,15(3):140-141.
-
9郑佩君.肝癌介入治疗的护理[J].现代中西医结合杂志,2007,16(28):4228-4228.
-
10何平.妇科常见癌症的筛检与预防[J].实用妇科内分泌电子杂志,2016,3(4):14-14. 被引量：2
